Cordova Research Institute

Miami, Florida 33182

2 studies enrolling now · 17 studies all time

What they study most

Axillary Hyperhidrosis, Crohn Disease, Crohn's Disease, Diabetes Mellitus, Type 1, Diabetic Peripheral Neuropathic Pain, Diabetic Peripheral Neuropathy, Gout, Healthy Volunteers, Hidradenitis Suppurativa (HS), Lumbosacral Radiculopathy, Multiple Sclerosis, Relapsing-Remitting, Proteinuric Kidney Disease

Studies at this site

• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa — Recruiting now
• Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection — Stopped early
• Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis — Running, not enrolling
• Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout — Completed
• Extension Study of ABP-671 in Participants With Gout — Stopped early
• A Study of RBI-4000 in Healthy Participants — Stopped early
• Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease — Stopped early
• Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302) — Completed
• Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease — Completed
• Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain — Completed
• Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain — Completed
• Mylan Insulin Aspart Study — Completed
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis — Completed
• Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse — Completed
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease — Withdrawn before enrolling